Abbvie IncABBV
Price$283.40Intrinsic value$195.2031% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $195.20median of 5 methods · middle span $178-$260based on filings through 30 Jun 2026
Market Price $283.40Price as of 15 Oct 2026
Margin of Safety -31.1%as of 15 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 26.0%/yr (balance of the path).21.5% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 621.4%Yr 716.8%Yr 812.2%Yr 97.6%Yr 103.0%
26.0% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)-6.1%
Discount rate (cost of equity) 7.3%
Volatility vs market (adjusted beta)0.53

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetAbbvie IncABBVHealth Care
Valuation
P/E80.1×
P/S7.3×
P/B—
EV / Revenue8.2×
EV / EBITDA27.0×
Profitability
Gross margin71.9%
Operating margin26.6%
Net margin9.8%
FCF margin28.3%
Returns
ROE—
ROA4.7%
ROIC12.1%
Growth
Revenue growth (YoY)14.3%
5-yr fwd EPS growth21.5%
Financial strength
Debt / Equity—
Current ratio0.81×
Altman Z-Score2.6
Interest coverage—
Dividend yield3.1%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.